HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Michele Maffezzoli Selected Research

Axitinib (AG 013736)

11/2022Takotsubo syndrome in a patient with metastatic renal cell carcinoma treated with pembrolizumab plus axitinib.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Michele Maffezzoli Research Topics

Disease

4Renal Cell Carcinoma (Grawitz Tumor)
04/2024 - 11/2022
3Neoplasms (Cancer)
10/2023 - 01/2023
1Takotsubo Cardiomyopathy
11/2022

Drug/Important Bio-Agent (IBA)

2NivolumabIBA
04/2024 - 04/2023
2Proteins (Proteins, Gene)FDA Link
04/2023 - 01/2023
1LDL Lipoproteins (beta Lipoproteins)IBA
10/2023
1oxidized low density lipoproteinIBA
10/2023
1Immune Checkpoint InhibitorsIBA
10/2023
1CholesterolIBA
10/2023
1LipidsIBA
10/2023
1HDL LipoproteinsIBA
10/2023
1Triglycerides (Triacylglycerol)IBA
10/2023
1pembrolizumabIBA
11/2022
1Axitinib (AG 013736)IBA
11/2022

Therapy/Procedure

3Immunotherapy
04/2024 - 04/2023